Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1997 Feb;52(2):114–119. doi: 10.1136/thx.52.2.114

Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome

H M Engleman, S E Martin, I J Deary, N J Douglas
PMCID: PMC1758499  PMID: 9059469

Abstract

BACKGROUND: Continuous positive airway pressure (CPAP) is an effective treatment in patients with moderate and severe sleep apnoea/hypopnoea syndrome (SAHS), but the minimum illness severity at which patients obtain benefit from CPAP is unclear. A study was therefore undertaken to investigate whether CPAP improves symptoms and daytime function in patients with mild SAHS. METHODS: Sixteen consecutively recruited patients with mild SAHS (5.0-14.9 apnoeas + hypopnoeas per hour slept and two or more symptoms of SAHS) participated in a prospective placebo controlled randomised crossover trial to assess the effects of CPAP on symptoms and daytime function. Patients spent four weeks on placebo and four weeks on CPAP, undergoing assessments of sleepiness, symptoms, cognitive performance, and well being on the last day of each treatment. Data from the placebo and CPAP assessments were compared. RESULTS: The mean (SE) objective effective use of CPAP was 2.8 (0.7) hours per night. Significant improvements in symptom score (-1.7 (0.5), p < 0.01), mental flexibility (-14 (5) seconds, p = 0.02), and depression rating (-1.6 (0.8), p = 0.03) on CPAP were observed. However, no significant differences in subjective or objective sleepiness were found. Ten of the 16 patients preferred CPAP and opted to continue with this treatment, although this proportion was non- significant (p > 0.4). The eight patients with best CPAP use showed an additional CPAP related improvement in quality of life (-4.4 (1.8), p = 0.03). Those who complied better with CPAP therapy also had a higher average microarousal frequency (p < 0.01) and apnoea+hypopnoea index (p = 0.02) than the poorer compliers. CONCLUSIONS: The results of this study provide evidence for improvements in symptoms and daytime function for patients with mild SAHS treated with CPAP. 




Full Text

The Full Text of this article is available as a PDF (151.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bédard M. A., Montplaisir J., Malo J., Richer F., Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol. 1993 Mar;15(2):330–341. doi: 10.1080/01688639308402567. [DOI] [PubMed] [Google Scholar]
  2. Cheshire K., Engleman H., Deary I., Shapiro C., Douglas N. J. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med. 1992 Mar;152(3):538–541. [PubMed] [Google Scholar]
  3. Downey R., 3rd, Perkin R. M., MacQuarrie J. Upper airway resistance syndrome: sick, symptomatic but underrecognized. Sleep. 1993 Oct;16(7):620–623. doi: 10.1093/sleep/16.7.620. [DOI] [PubMed] [Google Scholar]
  4. Engleman H. M., Asgari-Jirhandeh N., McLeod A. L., Ramsay C. F., Deary I. J., Douglas N. J. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest. 1996 Jun;109(6):1470–1476. doi: 10.1378/chest.109.6.1470. [DOI] [PubMed] [Google Scholar]
  5. Engleman H. M., Martin S. E., Deary I. J., Douglas N. J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994 Mar 5;343(8897):572–575. doi: 10.1016/s0140-6736(94)91522-9. [DOI] [PubMed] [Google Scholar]
  6. Findley L. J., Barth J. T., Powers D. C., Wilhoit S. C., Boyd D. G., Suratt P. M. Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. Chest. 1986 Nov;90(5):686–690. doi: 10.1378/chest.90.5.686. [DOI] [PubMed] [Google Scholar]
  7. Gall R., Isaac L., Kryger M. Quality of life in mild obstructive sleep apnea. Sleep. 1993 Dec;16(8 Suppl):S59–S61. doi: 10.1093/sleep/16.suppl_8.s59. [DOI] [PubMed] [Google Scholar]
  8. Gould G. A., Whyte K. F., Rhind G. B., Airlie M. A., Catterall J. R., Shapiro C. M., Douglas N. J. The sleep hypopnea syndrome. Am Rev Respir Dis. 1988 Apr;137(4):895–898. doi: 10.1164/ajrccm/137.4.895. [DOI] [PubMed] [Google Scholar]
  9. Guilleminault C., Stoohs R., Clerk A., Cetel M., Maistros P. A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest. 1993 Sep;104(3):781–787. doi: 10.1378/chest.104.3.781. [DOI] [PubMed] [Google Scholar]
  10. Johns M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  11. Kribbs N. B., Pack A. I., Kline L. R., Getsy J. E., Schuett J. S., Henry J. N., Maislin G., Dinges D. F. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis. 1993 May;147(5):1162–1168. doi: 10.1164/ajrccm/147.5.1162. [DOI] [PubMed] [Google Scholar]
  12. Kribbs N. B., Pack A. I., Kline L. R., Smith P. L., Schwartz A. R., Schubert N. M., Redline S., Henry J. N., Getsy J. E., Dinges D. F. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993 Apr;147(4):887–895. doi: 10.1164/ajrccm/147.4.887. [DOI] [PubMed] [Google Scholar]
  13. Lamphere J., Roehrs T., Wittig R., Zorick F., Conway W. A., Roth T. Recovery of alertness after CPAP in apnea. Chest. 1989 Dec;96(6):1364–1367. doi: 10.1378/chest.96.6.1364. [DOI] [PubMed] [Google Scholar]
  14. Moser N. J., Phillips B. A., Berry D. T., Harbison L. What is hypopnea, anyway? Chest. 1994 Feb;105(2):426–428. doi: 10.1378/chest.105.2.426. [DOI] [PubMed] [Google Scholar]
  15. Reeves-Hoche M. K., Meck R., Zwillich C. W. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med. 1994 Jan;149(1):149–154. doi: 10.1164/ajrccm.149.1.8111574. [DOI] [PubMed] [Google Scholar]
  16. Sangal R. B., Thomas L., Mitler M. M. Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders. Chest. 1992 Apr;101(4):898–902. doi: 10.1378/chest.101.4.898. [DOI] [PubMed] [Google Scholar]
  17. Thorpy M. J. The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association. Sleep. 1992 Jun;15(3):268–276. doi: 10.1093/sleep/15.3.268. [DOI] [PubMed] [Google Scholar]
  18. Whyte K. F., Allen M. B., Jeffrey A. A., Gould G. A., Douglas N. J. Clinical features of the sleep apnoea/hypopnoea syndrome. Q J Med. 1989 Jul;72(267):659–666. [PubMed] [Google Scholar]
  19. Zucconi M, Oldani A, Ferini-Strambi L, Calori G, Castronovo C, Smirne S. EEG arousal pattern in habitual snorers with and without obstructive sleep apnoea (OSA). J Sleep Res. 1995 Jun;4(2):107–112. doi: 10.1111/j.1365-2869.1995.tb00158.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES